The Opioid Treatment Accreditation Course (OTAC) is currently being restructured by the University of Sydney, Discipline of Addiction Medicine on behalf of NSW Health. The new format training is expected to commence June 2018 and will include content from the soon to be released, updated NSW Clinical Guidelines for the Treatment of Opioid Dependence. Be sure to watch this space as content will be updated periodically over the coming months.
The Fundamenals Course
The Fundamentals Training will comprise the following 2 modules:
Fundamentals of the NSW Opioid Treatment Program, which will cover:
- the benefits of opioids agonist treatment; and
- operation of the NSW Opioid Treatment Program, including legislation, safeguards, community pharmacy and management of stigma and discrimination.
Initiation of treatment with buprenorphine or buprenorphine/naloxone, which will cover the safe and effective prescribing of buprenorphine or buprenorphine/naloxone for opioid dependent individuals.
The Opioid Treatment Accreditation Course
The Opioid Treatment Accreditation Course will be the prerequisite for Participants to be accredited to prescribe opioid pharmacotherapies for treatment of opioid dependence in accordance with section 28 of the Poisons and Therapeutic Goods Act 1966 (NSW). This course will also include content related safe and effective prescribing of methadone for opioid dependent individuals.
The Fundamentals Training must be completed by a Participant as a prerequisite to that Participant enrolling in, and completing, the OTAC. Fundamentals Training may be undertaken as standalone training and is not mandatory for medical practitioners who prescribe buprenorphine or buprenorphine/naloxone for up to 30 opioid dependent patients.
If you are interested in further details or would like to be placed on the waitlist for the restructured course please contact Daniel Winter, OTAC Coordinator, at [email protected] or 02 9515 6407.